Patents Assigned to Merck Patent Gesellschaft mit Beschrankter Hafting
  • QUINAZOLINAMIDE DERIVATIVES
    Publication number: 20110245225
    Abstract: Novel quinazolinamide derivatives of the formula (I), in which R1-R5 and X have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
    Type: Application
    Filed: November 12, 2009
    Publication date: October 6, 2011
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTING
    Inventors: Hans-Michael Eggenweiler, Christian Sirrenberg, Hans-Peter Buchstaller
  • PROCESS FOR PREPARING AN ELECTRONIC DEVICE
    Publication number: 20100108999
    Abstract: The invention relates to a process for preparing an electronic device using a protection layer, and to improved electronic devices prepared by this process, in particular organic field effect transistors (OFETs).
    Type: Application
    Filed: March 28, 2008
    Publication date: May 6, 2010
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTING
    Inventors: David Christoph Mueller, Toby Cull, Simon Dominic Ogier
  • Arylbenzoylguanidines
    Patent number: 5807896
    Abstract: Arylbenzoylguanidines of the formula I ##STR1## in which R.sup.1 R.sup.2, R.sup.3 and Ph have the given meanings herein, and also the physiologically harmless salts thereof, exhibit antiarrhythmic properties and act as inhibitors of the cellular Na.sup.+ /H.sup.+ antiporter.
    Type: Grant
    Filed: August 25, 1995
    Date of Patent: September 15, 1998
    Assignee: Merck Patent Gesellschaft mit Beschrankter Hafting
    Inventors: Rolf Gericke, Dieter Dorsch, Manfred Baumgarth, Klaus-Otto Minck, Norbert Beier